Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02875548
Title Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements No
Sponsors Epizyme, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | BEL | AUS


No variant requirements are available.